The Decipher test can be used to predict death and metastases in some patients with prostate cancer, according to findings that were recently presented.
Timing is Key: Smoking Cessation Successful When Tele-Counseling and Lung Cancer Screening Are Paired
Telephone-based smoking cessation counseling helped patients quit smoking, according to a recent study.
In a recent phase 3 trial, Lynparza improved progression-free survival in patients with BRCA-positive, HER2-negative breast cancer.
Rova-T proved to be safe and effective in patients with small cell lung cancer according to a recent study.
A supplemental biologics license application was filed for Blincyto to be approved for certain patients with ALL.
Padeliporfin vascular-targeted photodynamic therapy may be a promising option for men with low-risk prostate cancer, according to the results of a recent study.
2016 was an exciting year for non-small cell lung cancer, and more advances are expected for 2017.
STARTRK-2 trial is a currently enrolling trial to test the efficacy and safety of the agent entrectinib which targets 5 abnormalities across a number of cancer sites.
Researchers at the University of Michigan are hoping to improve the survival rates for laryngeal cancer.